Abstract:Objective:To evaluate the ability of vascular endothelial growth factor receptor 2(VEGFR2)/integrin α vβ 3 dual-targeted microubble (MBD) to target angiogenesis of renal cell carcinoma (RCC) in vivo. Methods:Non-targeted microbubble (MBN) USphere LA was employed as a template to prepare single- and dual-targeted microbubbles which could bind VEGFR2 and/or integrin α vβ 3 (MBV and MBI) by the biotin-avidin bridging method. A total of 40 RCC nude mice models were established by subcutaneously injecting 786-O cells.Twenty of the models were all injected with MBN, MBV, MBI and MBD in a random order, and the other 20 models were registered for antibody blocking assays. The results of ultrasound images were used for quantitative analyses, and the following quantitative parameters were obtained: intensity increment (a 1), peak halving speed (a 2), curve rising slope (a 3), perfusion time (t 0), time to peak (TTP), peak intensity (PI), mean transit time (MTT) and area under the curve (AUC) for the first three minutes, peak intensity at 10 s before (P 1) and after (P 2) ultrasound destruction, and the differences of tissue enhancement (dTE) between P 1 and P 2 (dTE=P 1-P 2). All the quantitative parameters of four contrast agents and the antibody blocking assays were compared.Besides, the immunohistochemical assays were performed to evaluate the expression of CD31, VEGFR2 and integrin α vβ 3 in tumor tissues. Results:The differences of parameters of a 1, a 3, t 0, TTP, PI and P 2 among four different microbubbles had no statistical significances (all P>0.05), and all parameters between the two single-targeted contrast agents were not statistically different (all P>0.05). The parameters of AUC, MTT, P 1 and dTE all showed a trend that dual-targeted bubbles > single-targeted bubbles > non-targeted bubbles (all P<0.05). On the contrary, the trend of dual-targeted bubbles < single-targeted bubbles < non-targeted bubbles (all P<0.05) was observed for a 2. In the antibody blocking experiment, a 2 was faster after the antibody injection ( P<0.001), while AUC, MTT, P 1 and dTE were all lower than those before the antibody injection ( P<0.001), and the other parameters were not statistically different before and after the antibody injection (all P>0.05). Immunohistochemical analyses confirmed the high expression of CD31, VEGFR2 and integrin β 3 in tumor tissues. Conclusions:The VEGFR2 and integrin α vβ 3 dual-targeted microbubble has a good potential to target the angiogenesis of human RCC in vivo.

Experimental study of interaction between activated VWF and targeted lipid microbubbles conjugated with recombinant GPⅠba

Experimental Study of Interaction Between Activated VWF and Targeted Lipid Microbubbles Conjugated with Recombinant GPIba

Study on integrin-mediated albumin microbubbles adherence to activated leukocytes

Mechanism study on behavior of albumin microbubbles in myocardium undergoing ischemia-reperfusion

Study on Hypovascular Tumor' S Treatment with Targeted Mierobubbles Combined with Ultrasonic Abrupted Destroy

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

Characteristics of VEGFR2-targeted Lipid Microbubbles Contrast-Enhanced Ultrasound in Nude Mice with Subcutaneous Colonic Carcinoma Xenografts: Compared with Lipid Microbubbles

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Binding properties of flowing fibrin-targeted microbubbles evaluated with a thrombus-embedded microchannel

Microbubble Biointerfacing by Regulation of the Platelet Membrane Surfactant Activity at the Gas‐Liquid Interface for Acute Thrombosis Targeting

Preparation of Vascular Endothelial Growth Factor Receptor 2/integrinαv Β3 Dual‐targeted Contrast Ultrasound Agent and Its Ultrasound Imaging Features and Targeted Ability :A in Vitro Study

Ultrasound Molecular Imaging of Arterial Thrombi with Novel Microbubbles Modified by Cyclic Rgd in Vitro and in Vivo

Harnessing platelets as functional vectors for contrast enhanced ultrasound imaging and fluorescence imaging

Distinct platelet interactions with soluble and immobilized von Willebrand factor modulate platelet adhesion and aggregation with differential impact on hemostasis and thrombosis

Hemodynamic Mimic Shear Stress for Platelet Membrane Nanobubbles Preparation and Integrin α IIb β 3 Conformation Regulation

Platelet membrane-derived biomimetic microbubbles with enhanced targeting ability for the early detection of myocardial ischemia-reperfusion injury

Hemodynamic Mimic Shear Stress for Platelet Membrane Nanobubbles Preparation and Integrin Αiibβ3 Conformation Regulation

Dual-Targeted Microbubbles Specific to Integrin Αvβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.

Experimental study of vascular endothelial growth factor receptor 2 and integrin α vβ 3 dual-targeted microbubble to assess tumor angiogenesis of renal cell carcinoma in vivo

Preparation of vascular endothelial growth factor receptor 2-targeted ultrasonic contrast agent and its ability oftargeting tumor cellsin vitro

Controlled in vivo Bone Formation and Vascularization Using Ultrasound-Triggered Release of Recombinant Vascular Endothelial Growth Factor From Poly(D,L-lactic-co-glycolicacid) Microbubbles